Elevai Labs (ELAB) Short Interest Ratio & Short Volume → America could fall from this event (From Porter & Company) (Ad) Free ELAB Stock Alerts $0.65 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Elevai Labs Short Interest DataCurrent Short Volume83,800 sharesPrevious Short Volume54,800 sharesChange Vs. Previous Month+52.92%Dollar Volume Sold Short$58,718.66Short Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Outstanding Shares17,330,000 sharesPercentage of Shares Shorted0.48%Today's Trading Volume65,142 sharesAverage Trading Volume1,108,144 sharesToday's Volume Vs. Average6% Short Selling Elevai Labs ? Sign up to receive the latest short interest report for Elevai Labs and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELAB Short Interest Over TimeELAB Days to Cover Over TimeELAB Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Elevai Labs Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202483,800 shares $58,718.66 +52.9%N/A0.2 $0.70 4/15/202454,800 shares $31,510.00 +66.1%N/A0.1 $0.58 3/31/202433,000 shares $22,935.00 -34.7%N/A0 $0.70 3/15/202450,500 shares $36,915.50 -76.0%N/A0 $0.73 2/29/2024210,200 shares $146,509.40 +43.2%N/A0.1 $0.70 2/15/2024146,800 shares $106,885.08 -80.0%N/A0.1 $0.73 1/31/2024733,100 shares $506,572.10 No ChangeN/A0.5 $0.69 ELAB Short Interest - Frequently Asked Questions What is Elevai Labs' current short interest? Short interest is the volume of Elevai Labs shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 83,800 shares of ELAB short. Learn More on Elevai Labs' current short interest. Is Elevai Labs' short interest increasing or decreasing? Elevai Labs saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 83,800 shares, an increase of 52.9% from the previous total of 54,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elevai Labs' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Elevai Labs: ABVC BioPharma, Inc. (7.35%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Molecular Templates, Inc. (4.68%), Akari Therapeutics, Plc (0.03%), Imunon, Inc. (3.95%), Guardion Health Sciences, Inc. (14.33%), Addex Therapeutics Ltd (1.85%), Aeterna Zentaris Inc. (0.34%), Purple Biotech Ltd (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Elevai Labs stock? Short selling ELAB is an investing strategy that aims to generate trading profit from Elevai Labs as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elevai Labs? A short squeeze for Elevai Labs occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELAB, which in turn drives the price of the stock up even further. How often is Elevai Labs' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELAB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ABVC Short Squeeze MBRX Short Squeeze MIRA Short Squeeze MTEM Short Squeeze AKTX Short Squeeze IMNN Short Squeeze GHSI Short Squeeze ADXN Short Squeeze AEZS Short Squeeze PPBT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELAB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityNot Trump. Not Biden. But ___________.The Freeport SocietyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media